Management Report
Subsequent Events
Since March 31, 2008, no events of special significance have occurred that we expect to have a material impact on the financial position or results of operations of the Bayer Group.
11 of 11
- Home
- Key Data
- Bayer-Stock
- Management Report
- Financial Statements
- News
Nexavar® approved in Japan - Fungicidal active ingredient receives registrations in Japan and the United States
- Bayer Sustainable Development Report honored
- Bayer acquires OTC business of Sagmel
- Jatropha: new biofuel source offers great potential
- New design for Aspirin® packaging
- Bayer subsidiary Medrad acquires
- Partnership with Hyundai on the “i-mode” concept car
- Carbon nanotubes for new thermoplastic materials
- New food chain partnership project in Brazil
- Bayer and Cologne University Hospital launch collaboration
- Support for people with hemophilia
- Collaboration in veterinary medicine
- Services
- Overview of Sales, Earnings and Financial Position
- Future Perspectives
- Performance by Subgroup and Segment
- Calculation of EBIT(DA) Before Special Items
- Liquidity and Capital Resources
- Employees
- Risk Report
Subsequent Events
Bayer Links- Bayer Global
- Bayer HealthCare
- Bayer CropScience
- Bayer MaterialScience
- Bayer Business Services
- Bayer Technology Services
- Currenta
- Special Interest
Investor Relations- Press
- Jobs and Career
- Culture
Bookmark this page
E-mail this page
Search
Advanced Search
Links
Services
Calendar
Info
